Search Results - "Neild, Annie"

Legionella Reveal Dendritic Cell Functions that Facilitate Selection of Antigens for MHC Class II Presentation by Neild, Annie L, Roy, Craig R

“…To understand how adaptive immune responses are generated against bacteria that avoid being delivered to lysosomes, interactions between professional…”
Get full text

Kinetics and Cellular Origin of Cytokines in the Central Nervous System: Insight into Mechanisms of Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis by Juedes, Amy E, Hjelmstrom, Peter, Bergman, Cheryl M, Neild, Annie L, Ruddle, Nancy H

“…Experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein (MOG) in C57BL/6 (H-2b) mice is characterized by early (day 12) acute…”
Get full text

Immunity to vacuolar pathogens: What can we learn from Legionella? by Neild, Annie L., Roy, Craig R.

“…Summary Intracellular pathogens can manipulate host cellular pathways to create specialized organelles. These pathogen‐modified vacuoles permit the survival…”
Get full text

Activated Macrophages Infected with Legionella Inhibit T Cells by Means of MyD88-Dependent Production of Prostaglandins by Neild, Annie L, Shin, Sunny, Roy, Craig R

“…To understand how macrophages (Mphi) activated with IFN-gamma modulate the adaptive immune response to intracellular pathogens, the interaction of…”
Get full text

Processing and Major Histocompatibility Complex Class II Presentation of Legionella pneumophila Antigens by Infected Macrophages by Neild, Annie, Murata, Takahiro, Roy, Craig R

“…To better understand interactions between the intracellular pathogen Legionella pneumophila and macrophages (M[phi]s), host and bacterial determinants…”
Get full text

Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib by Dunn, Allison, Ditmarsch, Marc, Kastelein, John J. P., Kling, Douglas, Neild, Annie, Davidson, Michael H., Gobburu, Joga

“…Obicetrapib is a selective inhibitor of cholesteryl ester transfer protein that is currently in phase 3 of development for the treatment of dyslipidemia as…”
Get full text

Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN by Nicholls, Stephen J., Nelson, Adam J., Ditmarsch, Marc, Kastelein, John J.P., Ballantyne, Christie M., Ray, Kausik K., Navar, Ann Marie, Nissen, Steven E., Golberg, Anne C., Brunham, Liam R., Curcio, Danielle, Wuerdeman, Erin, Neild, Annie, Kling, Douglas, Hsieh, Andrew, Dicklin, Mary R., Ference, Brian A., Laufs, Ulrich, Banach, Maciej, Mehran, Roxana, Catapano, Alberico L., Davidson, Michael H.

“…Obicetrapib, a novel, selective cholesteryl ester transfer protein (CETP) inhibitor, reduces low-density lipoprotein cholesterol (LDL-C), LDL particles,…”
Get full text

Acquired immune responses following Legionella infection of antigen presenting cells by Neild, Annie Laurie

“…Legionella are members of a class of pathogens that reside in non-degradative compartments within professional antigen presenting cells (APCs). The adaptive…”
Get full text